Company / Revenue per Share
Stoke Therapeutics, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.41
FY2025
5-year range
$0.19 / $3.41
FY2022-FY2025
Trend
+1685.0%
vs FY2024
Sector context
#73 of 154
Health Care
What the data says
Revenue per Share changed +1685% YoY in FY2025, a notable deviation from the 3-year average annual change of +546%.
Based on SEC 10-K filings.
3.41 in FY2025 with a 3-year CAGR of +116.5%.
Improved from $0.31 to $3.41 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +116.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 154 in Health CareTop 47% of 154This company $3.41 Sector average $15.09
▼
-77.4% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 1685.0% year-over-year.
- Ranks #73 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.41 | +1685.0% |
| FY2024 | $0.19 | -39.2% |
| FY2023 | $0.31 | -6.4% |
| FY2022 | $0.34 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026